FSD Pharma Inc. (HUGE): Price and Financial Metrics
GET POWR RATINGS... FREE!
HUGE Stock Summary
- HUGE has a market capitalization of $15,947,114 -- more than approximately merely 3.49% of US stocks.
- HUGE's went public 1.19 years ago, making it older than just 0.52% of listed US stocks we're tracking.
- Revenue growth over the past 12 months for FSD Pharma Inc comes in at 187.49%, a number that bests 96.83% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to FSD Pharma Inc are AMK, AVCO, ASM, SHWZ, and TRC.
- To check out FSD Pharma Inc's SEC filings, go to the company's page on browse-edgar?action=getcompany&CIK=0001771885.
HUGE Stock Price Chart Interactive Chart >
HUGE Price/Volume Stats
|Current price||$1.70||52-week high||$4.44|
|Prev. close||$1.68||52-week low||$1.28|
|Day high||$1.70||Avg. volume||2,002,625|
|50-day MA||$1.75||Dividend yield||N/A|
|200-day MA||$1.84||Market Cap||61.19M|
FSD Pharma Inc. (HUGE) Company Bio
FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, GI tract, and musculoskeletal system, such as chronic pain. FSD Pharma Inc. has strategic alliance agreements with SciCann Therapeutics Inc., CannTab Therapeutics, and Solarvest BioEnergy Inc. The company was founded in 1998 and is headquartered in Toronto, Canada.
HUGE Latest News Stream
|Loading, please wait...|
HUGE Latest Social Stream
View Full HUGE Social Stream
Latest HUGE News From Around the Web
Below are the latest news stories about FSD Pharma Inc that investors may wish to consider to help them evaluate HUGE as an investment opportunity.
InvestmentPitch Media Video Discusses FSD Pharma's Termination of its CEO, Dr. Raza Bokhari, for Cause - Video Available on Investmentpitch.com
Vancouver, British Columbia--(Newsfile Corp. - July 28, 2021) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A), a specialty, biotech pharmaceutical R&D company, has terminated its CEO, Dr. Raza Bokhari, for cause. Following the company's shareholder meeting on May 14, 2021, Dr. Raza Bokhari was placed on administrative leave while a special committee comprised of two independent directors investigated various concerns regarding Dr. Bokhari's actions in his capacity as CEO.InvestmentPitch
TORONTO, July 27, 2021--FSD Pharma Inc. (Nasdaq: HUGE) (CSE:HUGE) (FRA:0K9) (the "Company" or "FSD") announced today that the board of directors had terminated the employment of the Company’s Chief Executive Officer, Dr. Raza Bokhari for cause.
FSD Pharma Inc. is pleased to announce the appointment of Mr. Adnan Bashir as an independent member of its Board of Directors, upon the recommendation of the Companys Compensation, Nomination and Governance Committee.
Fsd Pharma Inc Cl B (NASDAQ: HUGE) shares fell -4.00% to end trading Wednesday at $1.68 per share - a net change of $-0.07. Shares traded between $1.74 and $1.65 throughout the day. 390416 shares of Fsd Pharma Inc Cl B exchanged hands. Visit Fsd Pharma Inc Cl Bs profile for more information. About The Nasdaq Stock Market The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world\''s leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook. To get more information on Fsd Pharma Inc Cl B and to follow the companys latest updates, you can visit the companys profile page here: Fsd Pharma Inc Cl Bs Profile . For more news on the financial markets be su...
FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9) announced that the slate of board of directors nominees brought forward by a group of concerned shareholders received the necessary votes at the companys annual general and special meeting on May 14. The nominees of the concerned group, led by Anthony Durkacz and Zeeshan Saeed, were each elected, along with Frank Lavelle and Donal Carroll, to hold office for the ensuing year. However, following his election, Lavelle resigned, the company said. Nitin Kaushal and Larry Latowsky are the boards remaining two directors. We are pleased to see that FSD shareholders have shown their overwhelming support for the concerned shareholders and the concerned shareholders nominees, Durkacz and Saeed said in a statement. We look forward to restoring FSD ...
HUGE Price Returns